Leadership Overview
Merck KGaA has 5 executives leading key functions including diversity and inclusion, finance, strategy, operations, and communications.
Driven by a legacy of innovation, Merck KGaA is dedicated to advancing science and technology to improve lives globally, fostering a culture of collaboration and scientific excellence across its multinational operations.
Driven by a legacy of innovation, Merck KGaA is dedicated to advancing science and technology to improve lives globally, fostering a culture of collaboration and scientific excellence across its multinational operations.
Leadership Roles at Merck KGaA
Anne Ishikiriyama - Chief Financial Officer (Brazil)
Anne Ishikiriyama, the Chief Financial Officer (Brazil) at Merck KGaA, manages all financial operations within the Brazilian market. Ishikiriyama oversees budgeting, forecasting, and financial reporting, ensuring fiscal responsibility and strategic resource allocation. This role involves close collaboration with regional business units to drive profitable growth and optimize financial performance. The Chief Financial Officer (Brazil) is responsible for implementing global financial strategies tailored to the specific economic landscape of Brazil. Anne Ishikiriyama's leadership ensures compliance with local financial regulations and contributes to the overall financial health of Merck KGaA's operations in the Americas. By providing critical financial insights, Ishikiriyama supports informed decision-making and strengthens the company's market position.
Kevin McCafferty - President USW 10-00086
Kevin McCafferty, the President USW 10-00086 at Merck KGaA, directs the strategic vision and operational execution for the USW 10-00086 business unit. McCafferty oversees all aspects of the unit's performance, including market expansion, product development, and revenue generation. This leadership role involves fostering innovation and ensuring alignment with Merck KGaA's broader corporate goals. The President USW 10-00086 is responsible for building and leading high-performing teams to achieve ambitious targets. Kevin McCafferty's strategic guidance is essential for navigating complex market dynamics and capitalizing on emerging opportunities within the pharmaceutical and life sciences sectors. By driving operational excellence, McCafferty strengthens Merck KGaA's competitive advantage and market leadership.
Iman Griffin - Global Diversity & Inclusion Center of Excellence Chief of Staff
Iman Griffin, the Global Diversity & Inclusion Center of Excellence Chief of Staff at Merck KGaA, directs the strategic implementation of diversity and inclusion initiatives across the organization. Overseeing the operational framework for the Center of Excellence, Griffin ensures equitable access to resources and opportunities for all employees. This leadership position involves collaborating with regional leaders to embed inclusive practices into talent management and business operations. Griffin drives the development of programs that foster a sense of belonging and enhance employee engagement, directly supporting Merck KGaA's commitment to a diverse workforce. The Chief of Staff's efforts focus on creating a sustainable culture of inclusion that reflects the company's global presence and values. Iman Griffin's strategic oversight ensures that diversity and inclusion are integral to Merck KGaA's long-term success and market competitiveness.
Dana Gardner - Chief of Staff To Senior Vice President, Value and Implementation
Dana Gardner, the Chief of Staff To Senior Vice President, Value and Implementation at Merck KGaA, provides strategic support and operational coordination for value and implementation initiatives. Gardner facilitates communication and alignment between the Senior Vice President and various functional teams, ensuring seamless execution of strategic projects. This position involves managing key priorities, driving process improvements, and enhancing the overall efficiency of the value and implementation functions. Dana Gardner's role is critical in translating high-level strategies into actionable plans that support Merck KGaA's business objectives. By optimizing workflows and fostering cross-departmental collaboration, Gardner contributes directly to the successful delivery of value-driven solutions across the organization. The Chief of Staff's focus remains on driving impactful outcomes and supporting the Senior Vice President's vision.
Kristen Garzone - Executive For The Head of Communications & Chief People Officer
Kristen Garzone, the Executive For The Head of Communications & Chief People Officer at Merck KGaA, provides executive-level support for critical communications and human resources functions. Garzone collaborates on developing and executing comprehensive communication strategies that enhance corporate reputation and employee engagement. This role involves managing key projects and initiatives that align with the objectives of both the Communications and Chief People Officer departments. Kristen Garzone's contributions are vital in ensuring consistent messaging and fostering a positive organizational culture across Merck KGaA's global operations. By supporting strategic people initiatives, Garzone plays a key part in talent acquisition, development, and retention, directly impacting the company's ability to attract and retain top talent. The executive's focus is on driving impactful outcomes in employee relations and corporate messaging.
Explore Leadership Teams in Manufacturing
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. Cambrex offers a range of specialized drug substance technologies and capabilities, including continuous flow, controlled substances, solid-state science, material characterization, stability storage, and highly potent APIs. In addition, Cambrex can support conventional dosage forms, including oral solids, semi-solids, and liquids, and has the expertise to manufacture specialty dosage forms such as modified-release, fixed-dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile, and non-sterile ointments.
Company Leadership

RG
RL
Cresco Labs is a multi-state, vertically integrated cannabis company that controls its cultivation, manufacturing, extraction, and packaging practices. Its facilities are powered by agronomists, manufacturing experts, and state-of-the-art agricultural equipment, all of which drive their commitment to quality, purity, and consistency. Cresco Labs packages, ships and distributes its products nationwide, including locations owned and operated by their team. Cresco Labs is headquartered in Chicago, Illinois.
Company Leadership DD
CR
GB

Eris Lifesciences Ltd is a prominent Indian pharmaceutical company specializing in branded formulations, particularly in the cardio-metabolic sector. The company offers a diverse range of products across various therapeutic areas including anti-diabetes, cardiovascular health, dermatology, and gynecology. Eris is committed to improving patient care through innovative initiatives and pioneering studies aimed at chronic lifestyle-related diseases. Their target clients include healthcare professionals and patients across India, with a focus on enhancing health outcomes.
Company Leadership VK
MM
GA
RemeGen is a biopharmaceutical company focused on developing innovative drugs for autoimmune diseases and cancers. Their flagship products include Telitacicept, a dual-target fusion protein for autoimmune conditions, and Disitamab Vedotin, an antibody-drug conjugate for cancer treatment. The company has a robust product pipeline with numerous drugs in various stages of research and development. RemeGen aims to serve patients globally, leveraging its advanced technology and strong scientific support.
Company Leadership JL
JF
KH
ST